عنوان البحث(Papers / Research Title)
Detection of OXA-23 among Carbapenem in Resistant Clinical Isolates of Klebsiella pneumoniae .
الناشر \ المحرر \ الكاتب (Author / Editor / Publisher)
ايمان محمد جار الله مسير
Citation Information
ايمان,محمد,جار,الله,مسير , Detection of OXA-23 among Carbapenem in Resistant Clinical Isolates of Klebsiella pneumoniae . , Time 21/01/2019 09:25:37 : كلية العلوم
وصف الابستركت (Abstract)
presencn clinical isolates of Klebsiella pneumoniae
الوصف الكامل (Full Abstract)
Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 435 Detection of OXA-23 among Carbapenem Resistant Clinical Isolates of Klebsiella pneumoniae in Hilla. Fatima Moeen Abbas Eman Mohammad Jarallah College of science for women College of science Babylon university Babylon university Fatima.abas99@yahoo.com Emanm.Jarallah@yahoo.com Abstract This study aimed to assess the presence of blaOXA-23 in clinical isolates of Klebsiella pneumoniae. During the period from April to August 2011, a total of 801 various clinical samples were collected from different hospitals in Hilla city. One hundred and seventy seven (22%) isolates were diagnosed as Klebsiella spp.,117 isolates belonged to K.pneumoniae . High prevalence of K.pneumoniae was detected in Babylon Teaching Hospital for Maternity and Pediatric with 65 isolates. Regarding clinical samples, highest rate were observed for stool samples 38 (27%) followed by sputum 19 (15%). All 117 K.pneumoniae isolates were primarily screened for ? - lactams resistance, 91 (78%) showed positive results for beta lactams . ?- lactam resistance isolates were underwent antimicrobial susceptibility to 26 antibiotics by Kirby-Bauer disk diffusion methods. High resistance rate was recorded for penicillins (carbenicillin and ampicillin) 99% and 94.5%,respectively .Carbapenem resistance was reported in 17 (18.7%) of K. pneumoniae isolates. The presence of blaOXA-23 gene was checked by Polymerase Chain reaction (PCR) and confirmed in 15 (88.2%) of isolates. Keywords: Klebsiella pneumoniae, carbapenem resistance ,OXA-23 ?-lactamase, Polymerase Chain Reaction. الخالصة هدت ا درت دس دح درة رلدح درد در ةدس د وجدوت مدوسوا درتا تا د و دو 23-OXA تدا دبتا ري اسلد درا ار دلة درس ولدح دو درةصدوع د 177 بردح ري اسلدح دتا درد د دود مم دح مد جد 117Klebsiella بردح ر دح ر دو pneumoniae. K مد مجمو 801 ا دح دسلسلو ومد مم دت م تد ل ا متا دح درة دح ور دسا مد تتدلدح ل د برد لدح 2011 أظ دسا در د إ ب أا دس دبتا pneumoniae. K دو بر د مد م تد ر تدا در لمدل ر د لح ودت د ع تودقد 65 بردح دمد ة د مصدتس در ا دح دة دا ا ا درتسدب38%( 27 )د رح ا ا درقت 19%( 15 )وقت دظ دس درم دا دلوردل رة دلح در دبتا رم د تدا درتا تا د و د 91 برح )78 )%ي ا مق ومح رم ت دتمر ا ا ودتموي ل ا دم تدسا ة دلح در دبتا درمق ومدح رم د تدا درتا تا د و ر م د تدا درةاولدح ر سلقدح د تد س درقدس )ياسبدل- رد وس( وأظ دسا در دددد إ ب أ دددد ددددرح ر مق ومددددح ي ددددا رم دددد تدا درت دددد ا 99 %رم دددد ت درا سب دددد ا و9445 %رم دددد ت دتمر دددد ا لمدددد أتددددتا 17(1847 )%بردددح مددد ري اسلددد pneumoniae. K مق ومدددح رم ددد تدا درا سبددد ت لو وم ددد ا هدددن در دددبتا ر اتدددت ددد مدددوس ا 23-blaOXA ت ق لدح د ح د ةا درت مدسا )Reaction Chain Polymerase )ويتد ا در د إ ب 15( 8242 )% مد در دبتا ي ا ة م ح ر موسا 23-blaOXA الكممات المفتاحية: ري اسل درا ار لة درس ولح رم تدا درا سب ت لو موسوا درتا تا و و 23-OXA ح ةا درت مسا Introduction Klebsiella pneumoniae is an opportunistic and major hospital –acquired pathogen that has the potential to cause sever morbidity and mortality, particularly in intensive care units and amongst pediatrics patients but also in medical and surgical wards (Branger et al.,1998; Decre et al.,1998; Podschun and Ullmann,1998). Klebsiella is the cause of 5-7.5 % of all nosocomial infections and the third most–common bacterial cause of hospital -acquired pneumonia (Jones,2010; Khorshidi et al.,2011). Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 436 Carbapenems are a group of ? -lactam antibiotics which considered as the last line of therapy for multidrug-resistant isolates that are prevalent in many Gramnegative bacterial species ,especially those producing ESBLs or/ derepressed AmpC ? -lactamase (Oueenan and Bush,2007; Peirano et al.,2009). However , more recently carbapenem –resistant K.pneumoniae have emerged in United States and various parts of the world (;Woodford et al.,2004; Peirano et al.,2009 ;Aktas et al .,2012;Sacha et al.,2012). This species is resistant to almost all available antimicrobial agents, and infections with this organism have been associated with high rates of morbidity and mortality, particularly among persons with prolonged hospitalization and those who are critically ill and exposed to invasive devices (e.g., ventilators or central venous catheters) (Wachino et al.,2004; Schwaber and Carmeli.,2008). The main mechanism of resistance to carbapenems in K.pneumoniae is through the production of a carbapenemase , those that hudrolyse imipenem and /or meropenem are classified in either Ambler classes A, B or D (genetic differences) or in Bush –Jacoby- Medieros groups 2f,3a or 3b (substrate preference and molecular structure). Although resistance is not limited to this mechanism solely , another method of resistance includes ESBLs and or / AmpC production coupled with outer membrane porin (OMP) alterations (Thomson, 2001) . Class D enzymes are OXA (for oxacillin hydrolyzing ) enzymes, which are penicillinases capable of hydrolyzing oxacillin and cloxacillin. These serine betalactamases are plasmid encoded and are found primarily in Pseudomonas aeruginosa, Acinetobacter baumannii ,and rarely in isolates of Enterobacteriaceae from the United States. The major concern with OXA carbapenemases is their ability to rapidly mutate and expand their spectrum of activity (Marsik and Nambiar.,2011). The first OXA enzyme with carbapenemase activity was found in an isolate of A. baumannii in 1985 from a patient in Scotland. This enzyme was called ARI-1(for Acinetobacter resistant to imipenem ) which was later renamed OXA-23 (Paton et al.,1993) .Among the carbapenem hydrolyzing OXA enzymes, there is 40-70% amino acid homology within groups and within the group the homology is 92.5% or higher. These enzymes have measurable activity against penicillins, early cephalosporins and imipenem (Walther-Rasmussen and Hoiby.,2006 ; Oueenan and Bush,2007). The present study was conducted to evaluate the prevalence of K.pneumoniae isolated from various clinical specimen in Hilla city, determine carbapenem resistant isolates and to detect blaOXA-23 gene by Polymerase Chain Reaction (PCR) method. Materials and Methods Bacterial isolates In the present study, a total of 801 clinical samples were collected during the period of five months from April to the end of August 2011 ,from patients hospitalized / or attended to different hospitals in Hilla city / Babylon Province, included: Babylon Teaching Hospital for Maternity and Pediatric, AL- Hilla Teaching Hospital, Merjan Teaching Hospital and Chest Diseases Center. All samples were cultured on MacConkey s agar (Himedia) and incubated at 37 C? for 24 hrs. Bacterial isolates of K. pneumoniae were identified to the level of species by using the standard biochemical tests according to methods described by Collee et al., (2006) and MacFaddin (2000), confirmatory identification was carried out by VITEK 2 system following manufacturers instructions. Screening Test for ? -lactam Resistance Preliminary screening of K.pnenmoniae isolates being resistant to ? -lactam antibiotics was carried out using pick and patch method (NCCLS,2003) .Results were Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 437 compared with E.coli ATCC 25922(College of Medicine ,University of Kufa) as a negative control. Antimicrobial susceptibility testing Antimicrobial susceptibility testing of ? -lactam resistant K.pneumoniae isolates was performed on Mueller-Hinton agar (Oxoid) plates by using Kirby-Bauer disk diffusion method (Bauer et al.,1966). The isolates were tested against the following antibiotics: Ampicillin (10µg), Carbenicillin (100 µg), Piperacillin (100 µg), Amoxicillin-clavulanic acid (30 µg), Cefotaxime (30 µg), Ceftazidime (30 µg), Ceftriaxone (30 µg), Cefepime (30 µg), Cefoxitin (30 µg), Aztreonam (30 µg), Cefaclor (10µg), Cefprozil (30µg), Imipenem (10 µg), Meropenem (10 µg), Ertapenam (10µg), Gentamicin (10 µg), Amikacin (30µg); Kanamycin (30µg) , Nalidixic acid (30 µg) , Ciprofloxacin (5µg) ; Levofloxacin (5µg) ; TrimethoprimSulfamethoxazole (25µg) Nitrofurantion (30µg), Chloramphenicol (30µg) ,Tetracycline (30µg) and Doxycycline (30µg). The cultures were incubated at 37 Co for 18 hrs under aerobic conditions and bacterial growth inhibition zones diameter were measured and interpreted in accordance with the Clinical and Laboratory Standards Institute (CLSI) guidelines (CLSI,2010).E. coli ATCC 25922 was used as the standard strain for antibiotic susceptibility testing. Molecular detection of blaOXA-23 gene DNA preparation DNA preparation from bacterial cells was performed by salting out method as described by Pospiech and Neuman (1995) with some modification and used as a template for PCR reaction . PCR amplification of blaOXA-23 gene. Polymerase chain reaction was used to amplify the entire sequence of blaOXA-23 gene. The primer (Bioneer) used for the amplification of this gene was : OXA-23/F (5- -TCTGGTTGTACGGTTTCAGC-3 - ) and OXA-23/R (5—AGT CTTT CCA AAA ATTTTG -3 - ).Amplification reaction mixture was carried out in a 25 µl reaction volume using 12.5 µl Go Taq Green Master Mix 2X (Promega), 5 µl DNA template, 2.5 µl of 10 pmol/ µl of specific up stream primers and, 2.5 µl of 10 pmol/ µl of specific down stream primers, 2.5 µl nuclease-free water. Cycling parameters of blaOXA-23 were as follows: an initial denaturation at 95 C? for 30sec, followed by 30 cycles of denaturation at 95 C? for 30 sec, anneling at 51 C? for1 min, extension at 72 C? for1 min. and a final extension step of 72 at 10 min.(Hujer et al.,2006;Srinvasan et al.,2009).The resulting PCR product was run in 1.5 % agarose gels and electric current was allowed at 70 volts for 2 hr. DNA bands were observed using UVTransilluminator and photographed with Gel documentation system. 100 bp DNA Ladder (Bioneer) was used to assess PCR product size. Results and Discussion Results of the present study revealed the presence of 177 (22%) isolates belonged to Klebsiella spp. (Table -1) .In a previous study in Hilla by Al- Charrakh (2005), 29(13.8%) Klebsiella spp. isolates were obtained from 209 clinical samples. Another study by Al-Muhannak (2010) reported that Klebsiella spp. was the second frequently 62 (30.5%) isolated organisms in Najaf hospitals. Podchun and Ullmann (1998) ,documented that the principle pathogenic reservoirs for transmission of Klebsiella are the gastrointestinal tract and the hands of hospital personnel which increase the likelihood of person – to -person transmission and contaminated equipments are also important factors promoting the spread of Klebsiella spp . Also table (1) showed that 117 (14.6%) isolates were identified as K. pneumoniae. This Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 438 result is similar to findings of local study in Hilla by Al-Saedi (2000) who stated that K. pneumoniae isolates comprised (15.3%) from 725 clinical samples . However, prevalence and distribution of K.pneumoniae varied among Hilla hospitals , Table (1) shows distribution of Klebsiella pneumoniae in Hilla hospitals: Babylon Teaching (23%) , Chest diseases centers (14.8%), Al-Hilla Teaching (11.1%) and Merjan Teaching (3%).This variation among hospitals related to specification of each hospital for receiving patients suffering from specific diseases related to those hospitals .High prevalence rate (23%) was detected in Babylon Teaching Hospital, this range may be related to that most patients received were infants and premature babies suffering from diarrhea, vomiting ,meningitis and premature neonates in ICU for long period ,followed by Chest Diseases Center (14.8%), which specified for examining outpatients sputum with respiratory problem most of them for diagnosis of tuberculosis. High prevalence rate may be related to that most patients were debilitated by other diseases like diabetes mellitus and bronchoplumonary diseases .It was mentioned that the oragansim is carried on respiratory tracts of about 10% of normal people ,who are borne to pneumonia if host defense are impaired (Levinson and Jawetz,2000). Results of the present study revealed that 569/801(71%) of other bacterial spp. isolates were recovered from clinical samples, (Table -1).There is no doubt that hospitals are typical environments for the presence of pathogens such as S.aureus E. coli, Klebsiella, Proteus, Morganella, Enterobacter, Citrobacter, Serratia, Acinetobacter and Pseudomonas spp. (Kucukates and Kocazeybek, 2002; Azimi et al., 2011 ). However, the dissemination of bacterial isolates in clinical samples may be due to their ability to cause different nosocomial infections and resistance to a wide range of antibiotics. Table (1): Distribution of bacterial isolates recovered from clinical samples among different hospitals in Hilla city. Hospital s name No. of sample No. (%) of Klebsiella spp. isolates No.(%) of K. pneumoniae isolates No. (%) of other bacterial spp. isolates No. (%) of no growth cultures Babylon Teaching Hospital for Maternity and Pediatric 282 103 (36.5%) 65(23%) 179 (63.5%) 0 (0%) Al- Hilla Teaching Hospital 261 51 (19 %) 29 (11.1%) 195 (75%) 15 (6%) Merjan Teaching Hospital 130 4 (3%) 4(3%) 86 (66%) 40 (31%) Chest Diseases Center 128 19 (14.8%) 19(14.8%) 109 (85.2%) 0 (0%) Total 801 177(22%) 117(14.6%) 569(71%) 55(7%) The results of Table (2) showed that the majority of K. pneumoniae isolates 38/141(27%) were obtained from stool samples. High prevalence of K. pneumoniae in stool samples was demonstrated by other researchers , Al-Saedi (2000) in Hilla , (14%) , Ali et al.(2010) in Jordon, (20%) .In sputum , K.pneumoniae was detected in Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 439 19/128 (15%) of samples .Increasing prevalence of K.pneumoniae in sputum was observed by other researchers ,Al- Muhannak (2010) ( (15.7%) and Al-Sehlawi (2012) ,(16%) . In this study, VITEK 2 system was used to confirm identification of Klebsiella to species and subspecies levels and to avoid variability in findings of biochemical tests. Results of the present study indicated that K.pneumoniae subsp. pneumoniae was the most frequent subspecies 77/117(9.6%), followed by K.pneumoniae subsp.ozaenae 34/117(4%) and K.pneumoniae subsp. rhinoscleromatis 6/117 (1%) (Table -2). Dominance of K.pneumoniae subsp. pneumoniae among all other subspecies was supported with a report documented by Al-Sehlawi (2012) ,who stated that K.pneumoniae subsp. pneumoniae was the most frequent occurring subspecies., accounting for 88.9% . Results showed that 26/141 (18%) of K.pneumoniae subsp. pneumoniae ,8/141 (6%) of K.pneumoniae subsp.ozaenae and 4/141(3%) of K.pneumoniae subsp. rhinoscleromatis were obtained from stool samples .Similar findings were recorded by Al-Charrakh (2005) who found that most Klebsiella spp. were recovered from stool samples and K.pneumoniae subsp pneumoniae was the most frequently 87% occurring subspecies followed by K.pneumoniae subsp.ozaenea (9.5%) and K.pneumoniae subsp. rhinoscleromatis (3.5%) . In sputum samples, the prevalence rate was 8/128 (6%) for K.pneumoniae subsp.pneumoniae , 9/128 (7%) for K.pneumoniae subsp. ozaenae and 2/128 (2%) for K.pneumoniae subsp. rhinoscleromatis. One study pointed out that the detection rates of K.pneumoniae subsp. pneumoniae, K.pneumoniae subsp. ozaenae and K.pneumoniae subsp. rhinoscleromatis in patients with lower respiratory tract infections in Najaf were (4.3%),(8.6%),and (8.6%), respectively (AlMuhannak,2010). Table (2): Numbers and percentages of K. pneumoniae subspecies among different clinical samples. Clinical sample No. of sample No. (%) of K. pneumoniae isolates No. (%) of K . pneumoniae subspecies K. pneumoniae subsp. pneumoniae K. pneumouiae subsp. ozaenae K. pneumoniae subsp. rhinoscleromatis Stool 141 38 (27%) 26(18%) 8(6%) 4(3%) Sputum 128 19 (15%) 8(6%) 9(7%) 2(2%) Vagina 116 18 (15.5%) 18(15.5%) 0(0%) 0(0%) Burn 153 18 (11.7%) 12(7.8%) 6(3.9%) 0(0%) Urine 97 10 (10%) 3(3%) 7(7%) 0(0%) Wound 60 8 (13.3%) 5(8.3%) 3(5%) 0(0%) Blood 58 3 (5%) 2(3%) 1(2%) 0(0%) Ear 30 2 (6.6%) 2(6.6%) 0 (0%) 0(0%) Eye 8 1 (12.5%) 1(12.5%) 0(0%) 0(0%) Throat 10 0(0%) 0(0%) 0(0%) 0(0%) Total 801 117(14.6%) 77(9.6%) 34(4%) 6(1%) Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 440 As shown in table (3) , 91/117 (78%) of K. pneumoniae isolates were resistant to ampicillin and amoxicillin. This result is in accordance with a study in Hilla by AlCharrakh (2005) who stated that 73.8% Klebsiella isolates obtained from clinical samples were resistant to both ampicillin and amoxicillin . Higher resistant to these antibiotics could be attributed not only to the production of ? - lactamases, but also other resistance mechanisms like decrease the affinity of target PBPs or decrease permeability of the drug into the cell (Jacoby and Munoz-Price,2005).There are three further resistance mechanisms include conformational changes in PBPs, permeability changes in the outer membrane, and active efflux of the antibiotic(Amyes,2003). Other studies reported that qnr genes (integron-associated) are associated with resistance to several classes of antibiotics including ?-lactam ( Paterson,2006) Table (3): ? - lactam resistant Klebsiella pneumoniae isolates recovered from different clinical samples. No. of K. pneumoniae isolates Susceptibility to ampicillin and amoxicillin No. (%) of resistant isolates No. (%) of sensitive isolates 117 91 (78%) 26 (22%)
All 117 K. pneumoniae isolates were screened for their antibiotic resistance against selected antibiotic agents of different classes (Fig.1). In the present study a high resistance was observed for penicillins (carbenicillin and ampicillin) with rates of resistance 90(99%) and 86(94.5%),respectively, whereas 75(82.4%) of isolates were resistance to piperacillin. This result is in agreement with a pervious study in Hilla by Al- Asady (2009) who found that all 15 (100%) ?-lactam resistant Enterobacteriaceae isolates were resistant to ampicillin , piperacillin and carbencillin . High resistance to this class of antibiotics may be due to widespread use of these antibiotics in Hilla hospitals. The lower resistance rate was observed to carbapenem antibiotics when imipenem displayed (10 %) resistance rate. In spite of the low level of resistance, this result is higher than that reported by other local studies contacted in Iraq which reported that the susceptibility of K.pneumoniae isolates collected from clinical and environmental samples to imipenem was (100%) (Hadi,2008; Al-Asady,2009;AlMuhannak,2010). Pathak et al(2012) demonstrated 2% resistance to imipenem by K.pneumoniae in a surveillance study in two hospitals in India .Reasons behind resistance may be due to inappropriate duration of antibiotic therapy and subtherapeutic concentrations of the drug (Paquero et al.,1997;Philippe et al.,1999). Meropenem antibiotics showed (17.6%) resistant rate. Meropenem is well – tolerated and offers several potential advantages , including greater in vitro activity against Gram –negative pathogens and the option of bolus administration (Verwaest et al.,2000) Beside these , problem of renal metabolism of imipenem , and risk of seizures (Prakash,2006)and availability of meropenem only in Hilla hospitals might be the reasons behind possible greater use of meropenem over imipenem and hence the high prevalence of resistance. Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 1 Figure (1): Antibiotics susceptibility profile of Klebsiella pneumoniae isolates by disk diffusion method (n=91). AMP,Ampicillin;PRL,Piperacillin;PY,Carbenicillin;AMC,Amoxi-clav;CTX,Cefotaxime;CAZ,Ceftazidime;CRO,Ceftraiaxone;FEP Cefepime; Fox,Cefoxitin; ATM,Aztreonam; CF,Cefaclor; CPR,Cefprozil; IMP,Imipenem; MEM,Meropenem; ETP,Ertapenem; CN, Gantamicin ; AK, Amikacin ; K, Kanamycin ; NA , Nalidixic acid ; CIP, Ciprofloxacin ; LE5 ,Levofloxacin ; SXT, Trimethoprim- Sulfamethoxazole;C,Chloramphenicol;F,Nitrofurantion;TE, Tetracycline;DO,Doxycycline. Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 1 All carbapenem resistant isolates were screened by PCR for the presence of blaOXA-23. Results confirmed that 15 (88.2%) isolates carrying blaOXA-23 (Fig.2). This represents the first report of OXA-23 among clinical isolates of K.pneumoniae in Hilla. Recently , blaOXA-48 mediated resistance to carbepenem has been reported in K.pneumoniae in Turkey [9].The present study found that the prevalence rate of blaOXA-23 in carbapenem –resistant K.pneumoniae isolates from Hilla hospitals is undoubtedly high. Figure (2): Agarose gel electrophoresis (1.5%agarose,70 % volt for 2-3 hrs) for blaOXA-23 gene product (ampilified size 606 bp) using DNA template of carbapenem-resistant K. pneumoniae isolates extracted by using salting out method. Lane (L), DNA moleculer size marker (100- bp Ladder).Lanes (K1,2,3, 4, 5, 7, 8, 10,11,12,13,14,15,16 and 17) of K. pneumoniae isolates show positive results with blaOXA-23 gene , lanes (K 6 and 9) show negative results with blaOXA-23 gene. L K1 K2 K3 K4 K5 K6 K7 K8 L 606 bp L K10 K11 K12 K13 K14 K15 K16 K17 2000 1600 1200 1000 900 800 700 600 500 400 300 200 100
K9 606 bp 2000 1600 1200 1000 900 800 700 600 500 400 300 200 100 bp bp 2000 1600 1200 1000 900 800 700 600 500 400 300 200 100 Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 2 References Aktas, Z.; Satana, D.; Kayacan, C.; Ozbek, B.; Gurler, N.; Somer, A.; Salman, N. and Aydin, A. E. (2012). Carbapenem resistance in Turkey: repeat report on OXA48 in Klebsiella pneumoniae and first report on IMP-1 beta- lactamsae in Escherichia coli. Afr. J. Microbiol. Res. 6(17): 3874-3878. Al-Asady , F.M.H.(2009) .Bacteriological Study on Extended-Spectrum BetaLactamases Produced by Enterobacteriaceae Isolated from Children with Bacteremia in Hilla City .M.Sc. Thesis .College of Medicine,Babylon University. Al- Charrakh, A. H. (2005). Bacteriological and Genetic Study on ExtendedSpectrum ? - Lactamases and Bacteriocins of Klebsiella Isolated from Hilla City. Ph. D. Thesis. College of Sciences, Baghdad University. AL- Muhannak, F. H. N. (2010). Spread of Some Extended Spectrum BetaLactamases in Clinical Isolates of Gram-Negative Bacilli in Najaf. M. Sc. Thesis. College of Medicine. Kufa University. Al-Saedi, I.A.B. (2000).Isolation and Identification of Klebsiella pneumoniae from Various Infection in Hilla Province and Detection of Some Virulence Factors Associated in Their Pathogenicity .M.Sc.Thesis.College of Sciences ,Babylon University. Al-Sehlawi,Z.S.R.(2012).Occurrence and Characterization of AmpC ? - Lactamases in Klebsiella pneumoniae from Some Medical Centers in Najaf .Ph.D.Thesis. College of Sciences ,Babylon University. Ali, S. Q.; Zehra, A.; Naqvi, B. S.; Shah, S, and Bushra, R. (2010). Resistance pattern of ciprofloxacin against different pathogens. Oman. Med. J. 25: 294-298. Amyes, S.G. (2003). Resistance to beta-lactams-the permutations.J. Chemother. 15 (6): 525-535. Azimi , L .; Motevallian , A; Namvar , A.E. ; Asghari, B. and Lari, A.R. (2011). Nosocomial infections in burned patients in Motahari hospital ,Tehran ,Iran .Derm. Res. and Prac. 1-4. Baquero F., Negri MC, Morosini Ml and Blazquez J.(1997). The antibiotic selective process: Concentration- specific amplification of low- level resistant populations. Ciba. Found. Symp .207:93-111. Bauer, A. W.; Kirby, W.M.M.; Sherris, J.C and Track, M. (1966). Antibiotic susceptibility testing by standardized single disc method .Am.J. Clin.Pathol.45: 493-496. Branger , C. ; Lesimple , A.L. ; Bruneau , B.; Berry ,P. and Zechovsky , N. (1998). Long –term investigation of the clonal dissemination of Klebsiella pneumoniae isolates producing extended- spectrum ?- lactamases in a university hospital .J .Med. Microbiol .47:201- 209. Clinical and Laboratory Standards Institute (CLSI). (2010). Performance standards for antimicrobial susceptibility testing; 20th. Informational Supplement. Approved standard M07-A8. Clinical and Laboratory Standards Institute. Collee, J. G.; Fraser, A. G.; Marmiom, B. P.; and Simmon, A. (1996). Mackie and McCarteny Practical Medical Microbiology. 4th ed. Churchill Livingstone Inc., USA. Decre , D. ; Gachot , B.; lucet , J. C. ; Arlet ,G.;Byergogne-Berezin,E.and Regnier,B. (1998) . Clinical and bacteriologic epidemiology of extended – spectrum ?lactamase –producing strains of Klebsiella pneumoniae in a medical intensive care unit .Clin . Infect . Dis. 27:843- 844. Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 3 Hadi, Z. J. (2008). Detection of Extended- Spectrum Beta-Lactamases of Escherichia coli and Klebsiells spp.Iisolated from Patients with Significant Bacteriuria in Najaf. M. Sc. Thesis. College of Medicine. Kufa University. Hujer, K.M.; Hujer, A.M.; Hulten, E.A.; Bajaksouzian, S.; Adams, J. M.; Donskey, C.J.; Ecker, D.J.; Massire, C.;Eshoo,M.W.; Sampath,R.; Thomson,J.; Rather, P.N.; Craft, D.W.; Fishbian, J.T.; Ewell, A.J.; Jacobes, M.R.; Paterson, D.L. and Bonomo, R.A. (2006). Analysis of antibiotic resistance genes in multidrug resistant Acinetobacter sp. isolates from military and civilian patients treated at the walter reed army medical center. Antimicrob. Agents Chemother. 50(12): 4114-4123. Jacoby, G.A. and Munoz-Price, L.S. (2005). The New ?-Lactamases. New England J. Med. 352: 380-91. Jones, R. N. (2010). Microbial etiologies of hospital – acquired bacterial pneumonia and ventilator- associated bacterial pneumonia. Clin. Infect. Dis. 51 (Suppl.1): S 81-S 87. Khorshidi, A.; Rohani, M. and Moniri, R. (2011). The prevalence and molecular characterization of extended- spectrum ? - lactamases- producing Klebsiella pneumoniae isolates recovered from Kashan hospital university , Iran. J.J.M. 4(4): 289-294. Kucukates, E. and Kocazeybek, B.(2002). High resistance rate against 15 different antibiotics in aerobic Gram- negative bacterial isolates of cardiology intensive care unit patients .Ind .J. Med. Microbiol. 20 (4) :208 -210. Levinson, W. and Jawetz, E. (2000). Medical Microbiology and Immunology. 4th edition. Appleton and Lange. MacFaddin, J. F. (2000). Biochemical Tests for Identification of Medical Bacteria. 3rd ed. Lippincott Williams and Wilkins, USA. Marsik, F. J. and Nambiar, S. (2011). Review of carbapenemases and AmpC- beta lactamases. Pediatr. Infect. Dis. J. 30 (12): 1094- 1095. National Committee for Clinical Laboratory Standards (NCCLS). (2003). Performance standards for antimicrobial disc susceptibility testing. Disc diffusion. 8th ed. Informational supplement. M100-S13. NCCLS. Wayne, Pa. Pathak, A.; Marothi, Y. ; Kekre, V.; Mahadik, K.; Macaden, R. and Lundborg, C. S. (2012). High prevalence of extended- spectrum ? - lactamase-producing pathogens: results of a surveillance study in two hospitals in Ujjain, India. Infect. Drug. Resist. 5: 65-73. Paterson, D.L. (2006). Resistance in Gram-Negative Bacteria: Enterobacteriaceae. American J .Med. 119: S20-S28. Paton, R.; Miles, R. S.;Hood, J.; Amyes, S. G.; Miles, R. S. and Amyes, S. G. (1993). ARI 1: ?-lactamase-mediated imipenem resistance in Acinetobacter baumannii. Int .J. Antimicrob .Agents. 2: 81-87. Peirano, G.; Seki, L.M.; Passos, V.L.V; Pinto, M.C.F.G.; Guerra, L.R. and Asensi, M.D. (2009).Carbapenem –hydrolyzing ? -lactamase KPC-2 in Klebsiella pneumoniae isolated in Rio de Janeiro,Brazil. J. Antimicrob. Chemother. 63: 265-268. Philippe ,E. ;Weiss, M. ;Shultz, JM.; Yeomans, F. and Ehrenkranz, NJ.(1999). Emergence of highly antibiotic- resistant Pseudomonas aeruginosa in relation to duration of empirical antipseudomonal antibiotic treatment. Clin. Perform. Qual. Health Care. 7: 83-87. Journal of Babylon University/Pure and Applied Sciences/ No.(2)/ Vol.(25): 2017 4 Podschun, R. and Ullmann, U. (1998). Klebsiella spp. as nosocomial pathogens: epidemiology, taxonomy, typing methods, and pathogenicity factors. Clin. Microbiol. Rev. 11: 589-603. Pospiech, T. and Neumann, J. (1995). In genomic DNA isolation Kieser eds. John Innes Center. Norwich NR4 7UH. U.K. Prakask, S. (2006). Carbapenem sensitivity profile amongst bacterial isolates from clinical specimens in Kanpur city. Indian J. Crit. Care. Med. 10: 250-253. Queenan, A. M. and Bush,K. (2007). Carbapenemases: the versatile ? - lactamases. J. Clin. Microbiol. Rev. 20 (3): 440-458. Sacha,P.T.;Ojdana,D.; Wieczorek ,P.;Klowska, W.;Krawczk,M.; Czaban,S.; Oldak,E .and Tryniszewska,E.(2012).Genetic similarity and antimicrobial susceptibility of Klebsiella pneumoniae –producing carbapenemase (KPC-2) isolated in different clinical specimens received from university hospitals in Notherastern Poland.Afr.J.Microbiol.6(41):6888-6892. Schwaber, M.J. and Carmeli, Y.(2008). Carbapenem-resistant Enterobacteriaceae: a potential threat. JAMA. .300(24):2911. Srinivasan, V. B.; Rajamohan, G., Panchdi, P.; Stevenson, K.; Tadesse, D.; Patchanee, P.; Marcon, M. and Gebreyes, W. A. (2009). Genetic relatedness and molecular characterization of multidrug resistant Acinetobacter baumannii isolated in central Ohio, USA. Ann. Clin. Microbiol. Antimicrobiol. 8: 21-31. Thomson, K.S. (2001). Controversies about extended-spectrum and AmpC betalactamases. Emerg. Infec. Dis. 7 (2): 333-336. Verwaest, C.; Belgian Multicenter Study Group. (2000). Meropenem versus imipenem / cilastatin as empirical monotherapy for serious bacterial infections in the intensive care unit. Clin .Microbiol. Infect. 6: 294-302. Wachino, J.; Doi, Y.and Yamane, K. (2004). Nosocomial spread of ceftazidimeresistant Klebsiella pneumoniae strains producing a novel class A b-lactamase, GES-3, in a neonatal intensive care unit in Japan. Antimicrob. Agents Chemother. 48: 1960–1967. Walther- Rasmussen, J. and Hoiby, N. (2006). OXA-type carbapenemases. J. Antimicrob. Chemother. 57: 373-383. Woodford, N.; Tierno, P. M. Young, K.; Tysall, L.; Palepou, M- F., I.; Ward, E.; Painter, R. E.; Suber, D. F.; Shung, D.; Silver, L. L.; Inglima, K.; Kornblum, J. and Livermore, D. M. (2004). Outbreak of Klebsiella pneumoniae producing a new carbapenem- hydrolyzing class A ? - lactamase , KPC-3 , in a New York medical center. Antimicrob. Agents Chemother. 48 (12): 4793-4799.
تحميل الملف المرفق Download Attached File
|
|